SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-18-011065
Filing Date
2018-10-12
Accepted
2018-10-12 16:18:06
Documents
8
Period of Report
2018-10-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT gtbp_8k.htm 8-K 29622
2 SEPARATION AGREEMENT gtbp_ex101.htm EX-10.1 6075
3 IMAGE gtbp_ex101000.jpg GRAPHIC 106592
4 IMAGE gtbp_ex101001.jpg GRAPHIC 128322
5 IMAGE gtbp_ex101002.jpg GRAPHIC 126054
6 IMAGE gtbp_ex101003.jpg GRAPHIC 82862
7 IMAGE gtbp_ex101004.jpg GRAPHIC 83102
8 IMAGE gtbp_ex101005.jpg GRAPHIC 24027
  Complete submission text file 0001654954-18-011065.txt   796793
Mailing Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362
Business Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-08092 | Film No.: 181120405
SIC: 2834 Pharmaceutical Preparations